S. Rapp

发表

Role of leukotrienes in endotoxin action in vivo.

D. Keppler, W. Hagmann, S. Rapp, 1987, Reviews of infectious diseases.

Leukotrienes in Endotoxin Shock

D. Keppler, W. Hagmann, S. Rapp, 1987 .

Inhibition of the Apical Sodium-Dependent Bile Acid Transporter Reduces LDL Cholesterol and ApoB by Enhanced Plasma Clearance of LDL ApoB

S. Rapp, J. Burnett, P. Barrett, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE−/− mice by SC-435 Published, JLR Papers in Press, June 16, 2003. DOI 10.1194/jlr.M200469-JLR200

S. Rapp, Yi Luo, B. Keller, 2003, Journal of Lipid Research.

Protection of Hippocampal Neurons from “Ischemic” Insult in Vitro by Acidic Amino Acid Antagonists

P. Contreras, S. Rapp, T. Lanthorn, 1988 .

ACIDIC AMINO ACID ANTAGONISTS

P. Contreras, S. Rapp, T. Lanthorn, 1988 .

Identification and characterization of rhesus macaque interleukin-8

J. Minnerly, S. Rapp, M. Bolanowski, 1995, Inflammation.

Selective induction of intercellular adhesion molecule-1 by interferon-gamma in human airway epithelial cells.

M. Holtzman, D. Look, S. Rapp, 1992, The American journal of physiology.

Leukotrienes and liver injury

D. Keppler, W. Hagmann, S. Rapp, 1985 .

Identification of the major endogenous leukotriene metabolite in the bile of rats as N-acetyl leukotriene E4.

D. Keppler, W. Hagmann, S. Rapp, 1986, Prostaglandins.

Leukotrienes as mediators in tissue trauma.

D. Keppler, W. Hagmann, S. Rapp, 1985, Science.

Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, T. Girard, 2009, Bioorganic & medicinal chemistry letters.

Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, P. Harris, 2010, Journal of medicinal chemistry.

Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, P. Harris, 2010, Bioorganic & medicinal chemistry letters.

Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2).

D. J. Garland, E. Reinhard, D. Reitz, 2005, Journal of medicinal chemistry.

Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).

D. J. Garland, E. Reinhard, D. Reitz, 2005, Journal of medicinal chemistry.

Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, T. Girard, 2009, Bioorganic & medicinal chemistry letters.

Inhibition of the Apical Sodium-Dependent Bile Acid Transporter Reduces LDL Cholesterol and ApoB by Enhanced Plasma Clearance of LDL ApoB

S. Rapp, J. Burnett, P. Barrett, 2002, Arteriosclerosis, thrombosis, and vascular biology.